Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
08 avr. 2024 10h00 HE
|
Curevo Vaccine
SEATTLE, April 08, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus vaccines with improved...
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix
07 janv. 2024 11h00 HE
|
Curevo Vaccine
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune response non-inferior to Shingrix, including...
Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference
21 déc. 2023 08h00 HE
|
Curevo Vaccine
SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe...
Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer
11 avr. 2023 07h30 HE
|
Curevo Vaccine
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe...
Did CDC Suppress Data on Chickenpox Vaccine? Asks Article in Journal of American Physicians and Surgeons
29 mars 2022 10h09 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- The chickenpox (varicella) vaccine has markedly decreased the incidence of chickenpox. Although chickenpox is almost always a mild disease,...
Fiber Cement Siding Market Size Worth $6,229.51 Mn, Globally, by 2028 at 6.7% CAGR - Exclusive Report by The Insight Partners
10 févr. 2022 13h37 HE
|
The Insight Partners
New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Fiber Cement Siding Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Material (Portland Cement, Silica,...
Pfizer und BioNTech schließen neue globale Kollaborationsvereinbarung zur Entwicklung des ersten mRNA-basierten Impfstoffs gegen Gürtelrose
05 janv. 2022 06h45 HE
|
BioNTech SE
Die dritte Kollaborationsvereinbarung der Unternehmen für mRNA-basierte Impfstoffe soll die Entwicklung eines verbesserten Impfstoffs gegen Gürtelrose beschleunigen; eine schwächende, entstellende und...
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
05 janv. 2022 06h45 HE
|
BioNTech SE
Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people all over...
TAMKO ANNOUNCES RICK “THE ROOFER”: A PROFESSIONAL RESOURCE FOR CONTRACTORS
25 juil. 2018 11h36 HE
|
TAMKO Building Products, Inc.
Joplin, Missouri, July 25, 2018 (GLOBE NEWSWIRE) -- TAMKO Building Products, Inc. is excited to announce a new resource for roofing industry professionals: Rick the Roofer, also known as Field Sales...
Expert Dermatologists Present Latest Information at 2018 AAD Annual Meeting
16 févr. 2018 10h00 HE
|
American Academy of Dermatology
SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Annual Meeting will take place from Feb. 16 to 20 at the San Diego Convention Center. The meeting will feature...